NCT02865720 - Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 8, 2016

Primary Completion Date

June 23, 2017

Study Completion Date

June 23, 2017

Conditions

Hereditary Angioedema (HAE)

Interventions

DRUG

CINRYZE 500 U

IV infusion administered twice weekly

DRUG

CINRYZE 1000 U

IV infusion administered twice weekly

Trial Locations (10)

Toyohashi Municipal Hospital, Toyohashi

Asahi General Hospital, Asahi

Gunma University Hospital, Maebashi

Kobe University Hospital, Kobe

Heart Life Hospital, Nakagusuku

Naha City Hospital, Naha

Shiman University Hospital, Izumo

Adachi kyosai Hospital, Adachi City

Hiroshima University Hospital, Hiroshima

Tomakomai City Hospital, Tomakomai